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Reaction of chromium(VI) with one equivalent of ascorbate was studied by electron paramagnetic resonance spectroscopy in the presence of 0.10
M 5,5-dimethyl-1-pyrroline-1-oxide (DMPO) at room temperature in 0.10 M (N-12-hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid]) (HEPES) and
0.05 M tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCI) buffers (pH 7.0, room temperature). Chromium(V), ascorbyl radical, and carbon-
based DMPO-radical adducts were observed. A higher level of Cr(V) was observed in HEPES buffer and a higher level of the DMPO-radical adducts
was observed in Tris-HCI buffer. Chromium-DNA binding studies were carried out in vitro for calf thymus DNA incubated with Cr(VI) and ascorbate
in both buffers at 37° C. Higher Cr-DNA binding was observed in HEPES buffer. DNA strand-break studies were carried out in vitro on pBR322 DNA
incubated with Cr(VI) and ascorbate in both buffers at 37° C. Higher percent nicking was observed in Tris-HCI buffer. Addition of DMPO decreased
nicking levels in Tris-HCI buffer. These results suggest that free radicals are more reactive than Cr(V) in producing DNA strand breaks and that Cr(V)
will react with DNA to produce Cr-DNA adducts. The fact that buffer affects the nature of the reactive intermediates produced upon reduction of
Cr(VI) may be related to differences in intracellular metabolism of Cr(VI) and resulting DNA damage observed in various cell culture systems and ani-
mal tissues in vivo. - Environ Health Perspect 102(Suppl 3):21-25 (1994).
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Introduction
Chromium(VI) (Cr(VI) is a known car-
cinogen (1). It causes respiratory cancers in
humans and animals, and it is mutagenic
and genotoxic (2). The mechanism of
Cr(VI)-induced carcinogenesis is unclear.
The intracellular reduction of Cr(VI) (3)
can produce many reactive intermediates,
including Cr(V), Cr(IV), free radicals, and
the final stable product Cr(III). Any of
these species could potentially target DNA.
Many types of DNA damage have been
observed with Cr(VI) in vivo and in vitro,
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including interstrand cross-links, DNA-
protein cross-links, strand breaks, Cr-DNA
adducts, and radical DNA adducts, most
notably 8-oxo-deoxyguanosine (4). Recent
work has shown that ascorbate (vitamin C)
is the principal reductant of Cr(VI) in rat
kidney, liver, and lung ultrafiltrates (5,6).
It is not yet fully understood whether the
intracellular reduction of Cr(VI) by ascor-
bate is a toxification or detoxification
process, i.e., does ascorbate protect tissues
against Cr(VI)-induced DNA damage by
reducing it to a substitutionally inert form,
Cr(III):
2Cr(VI) + 3ascorbate -e 2Cr(III)
+ 3dehydroascorbate
or does this process produce reactive inter-
mediates that are the actual genotoxic species?
The purpose of the current study was to
determine the reactive intermediates that
are produced upon reduction of Cr(VI) by
ascorbate and the extent to which these
intermediates, e.g., Cr(V) and free radicals,
would react with DNA in vitro.
Chromium(VI) was reacted with one
equivalent of ascorbate in (N-[2-hydroxy-
ethyl] piperazine-N'- [2-ethanesulfonic
acid]) (HEPES) or Tris(hydroxymethyl)-
aminomethane hydrochloride (Tris-HCl)
buffer and the intermediates were observed
by electron paramagnetic resonance (EPR)
spectroscopy. Reactions of Cr(VI) with
ascorbate were carried out in the presence
of calf thymus DNA or pBR322 DNA to
determine the amount of Cr-DNA adducts
and single-strand breaks, respectively.
Reactive Intermediates
Observed by EPR
Spectroscopy
EPR spectroscopy was used to determine
the reactive intermediates formed from the
reduction of Cr(VI) by ascorbate. EPR
spectra were acquired at room temperature
for a 1:1 stoichiometric ratio of Cr(VI)
(from K2Cr207) to sodium ascorbate at 9.0
mM, 3.6 mM, or 1.8 mM Cr(VI) and
sodium ascorbate with or without 0.10 M
5,5-dimethyl-1-pyrroline-1-oxide (DMPO)
in either 0.10 M HEPES (pH 7.0, room
temperature) or 0.05 M Tris-HCl (pH 7.0,
room temperature) buffers. Reactions at
1.8 mM Cr(VI) and ascorbate were run
with and without 1.8 mM calf thymus
DNA. Chromium(V) and carbon-based
free-radical adducts of DMPO were
observed under these conditions (Figure 1).
In HEPES buffer, Cr(V) had a g value of
1.980 and AH= 1.173 G (where AH is the
line width measured between the maxi-
mum and minimum of the first derivative
spectral peak); and in Tris-HCl buffer a
much weaker Cr(V) signal was detected at
g= 1.978. These intermediates were best
observed at high concentrations. Spectra at
the lower concentrations used for DNA
studies showed the same features, with dif-
ferences consisting of an overall decrease in
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Figure 1. EPR spectra of intermediates formed during reaction of Cr(VI) and ascorbate in HEPES versus Tris-HCI buffers.
(A) Cr(VI) (9.18, 3.63, or 1.82 mM, from K2Cr2O7) was reacted with sodium ascorbate (9.00, 3.63, or 1.82 mM) in 0.10 M
HEPES buffer (pH 7.0, room temperature) in the presence of 0.10 M DMPO. (B) CrVI) (9.00, 3.60, or 1.80 mM) was
reacted with sodium ascorbate (8.24, 3.80, or 1.80 mM) in 0.05 M Tris-HCI buffer (pH 7.0, room temperature) in the pres-
ence of 0.10 M DMPO. Spectra at 1.8 mM Cr(VI) and ascorbate were acquired in the presence of 1.8 mM calf thymus
DNA. Trace iron was removed from all buffer and ascorbate solutions by treatment with Chelex 100 resin. Ascorbate
concentrations were determined by U/Vis spectroscopy (265 nm, E= 14500 M-1 cm- (23)). DMPO solutions were puri-
fied by charcoal filtration (24). Solutions were made immediately before use. Reactions were initiated by addition of
Cr(VI) and spectra were acquired beginning at 80 sec reaction time and signal averaged over nine scans. EPR parameters
are as follows: 100 kHz field modulation, 1.0 G modulation amplitude, 1 x105 receiver gain, 9.772-9.769 microwave fre-
quency, 3430-3530 sweep width, and 21 sec scan time. The g values were calculated from calibration against DPPH
(g= 2.0036). Reactions were run in duplicate.
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Figure 2. Concentration of (A) Cr(V), and (B) ascorbate
radical and DMPO-radical adducts, produced upon reac-
tion of Cr(VI) (1.8 mM) with ascorbate (1.8 mM) in HEPES
versus Tris-HCI buffers determined by EPR spectroscopy.
Experimental conditions are given in Figure 1 caption.
Calculations are described in text; values on the graph are
averages ± SD. (n = 6 for HEPES data; n = 4 for Tris-HCI
data).
signal intensity and a slightly higher relative
signal intensity for ascorbate radical, and
higher amounts of carbon-based DMPO-
radical adducts in Tris-HCl vs HEPES
buffer. Concentrations of intermediates
were estimated from signal intensities
(IAH , where I is the signal intensity mea-
sured as peak to trough height from the
baseline of the first derivative spectra) by
comparison to signal intensities of standards
of known concentration, K3CrO8 for Cr(V)
(7) and TEMPO* (8) for ascorbate radical
and DMPO-radical adducts. At the 1.8
mM concentration of Cr(VI) and ascorbate,
the Cr(V) signal was 20-fold higher in
HEPES buffer than in Tris-HCI buffer
(Figure 2A). This difference in relative sig-
nal intensity, as well as the Cr(V) g value,
has been reported previously for reactions
of Cr(VI) with ascorbate (9,10) and is
assumed to result from reaction of
chromium with the Tris-HCl buffer.
HEPES buffer did not react with
chromium on this time scale as evidenced
by the identical EPR spectra for the same
reaction of Cr(VI) with ascorbate carried
out in phosphate, dimethylarsenate
(cacodylate) and HEPES buffers (10).
Three DMPO-radical adducts were distin-
guished with g values and hyperfine cou-
pling constants estimated from simulations
as follows: 1, g=2.007, AH= 25.7 G,
AN=15.5, G; 2, g=2.007, AH=18.8 G,
AN=15.5 G; and 3, g=2.007, AH=22.8 G,
AN=1 5.8 G. The relative hyperfine split-
tings AH>AN identify the DMPO-adducts as
being derived from carbon-based radicals
(11). These carbon radicals are assumed to
arise from fragmentation of ascorbate under
these reaction conditions. The hydroxyl
radical adduct of DMPO was not observed
(12). There was 2-fold more ascorbate radi-
cal detected for the reaction of Cr(VI) with
ascorbate in HEPES than Tris-HCl buffer
and 2-fold less DMPO-radical adducts pro-
duced by the reaction in HEPES buffer
than Tris-HCl buffer (Figure 2B). There
was 2-fold more DMPO-radical adduct
than ascorbate radical produced upon reac-
tion of Cr(VI) with ascorbate in HEPES
buffer and 8-fold more in Tris-HCl buffer.
The Cr(V) and DMPO-adduct signals were
not affected by the presence of DNA, and
DMPO had no effect on the signal inten-
sity of Cr(V) (data not shown).
These EPR experiments demonstrate that
the reduction of Cr(VI) by ascorbate in
HEPES or Tris-HCl buffers results in vari-
ous amounts and types of Cr(V) species and
varying amounts of radical species. This
allowed us to study the reactivity of Cr(V)
with DNA, and to distinguish between
Cr(V) and free radicals as being responsible
for Cr-DNA adducts in calf thymus DNA
and/or single-strand breaks in plasmid
DNA (below).
Chromium-DNAAdducts Resulting
fiom Reduction ofCr(VI) by
Ascorbate
The formation of Cr-DNA adducts was
measured after reacting Cr(VI) (1.8 mM,
from K2Cr207) with ascorbic acid (1.8
mM) in the presence of native (double-
stranded) or denatured (single-stranded)
calf thymus DNA (1.8 mM). Since EPR
spectroscopy (above) had shown a strong
buffer dependence on the level of Cr(V),
the reactions were carried out in both 0.05
M Tris-HCl buffer (pH 7.0, 37'C) and
0.10 M HEPES buffer (pH 7.0, 37'C) to
determine the role of Cr(V) in Cr-DNA
binding. Experiments carried out with
double-stranded vs single-stranded calf thy-
mus DNA allowed for evaluation of a pref-
erence for chromium to bind to the
nucleotide base rather than the sugar-phos-
phate backbone of DNA.
No Cr-DNA binding was detected upon
reaction of calf thymus DNA with Cr(VI)
in the absence of ascorbate. Reactions of
DNA with Cr(VI) in the presence of ascor-
bate resulted in higher Cr-DNA binding in
HEPES relative to Tris-HCl, with a 6.9-
fold difference for native calf thymus DNA
and a 9.3-fold difference for denatured
DNA (Figure 3). There was 3.3-fold higher
binding of chromium to single-stranded
DNA than native DNA in HEPES buffer,
and 2.4-fold higher binding to denatured
DNA in Tris-HCl buffer.
The higher Cr-DNA binding in HEPES
compared to Tris-HCl buffer correlates
with the higher relative level of the Cr(V)
intermediate produced during the reduc-
tion of Cr(VI) by ascorbate in HEPES.
The higher Cr-DNA binding observed
with single-stranded vs double-stranded
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DNA is consistent with previous work (13)
that suggested chromium is bound cova-
lently to the nucleotide bases, not simply
interacting electrostatically with the
anionic sugar-phosphate backbone.
Single-Strand Breaks in
Plasmid DNA Resulting from
Reduction of Cr(VI) by
Ascorbate
Single-strand breakage by the Cr(V) and
free radical intermediates was determined
using supercoiled pBR322 DNA. Reaction
of 1.8 mM Cr(VI) (from K2Cr207) with
1.8 mM sodium ascorbate in the presence
of 1.0 pg pBR322 DNA (0.36 pM DNA-P)
with 15 pM diethylenetriaminepentaacetic
acid (DETAPAC) in either 0.10 M HEPES
or 0.05 M Tris-HCl buffers (pH 7.0, 37° C)
resulted in significant nicking of plasmid
DNA relative to control reactions (Figure
4). Reaction of pBR322 DNA with Cr(VI)
in the presence of ascorbate showed 2-fold
higher nicking in Tris-HCI buffer relative
to reactions in HEPES buffer.
Chromium(VI) or ascorbate alone did not
cause any DNA single-strand breakage.
Addition of 0.10 M DMPO dramatically
decreased the extent of nicking of pBR322
DNA produced in reactions with Cr(VI) in
the presence of ascorbate in Tris-HCl
buffer (Figure 4). This is consistent with
the higher levels of free radicals observed in
Tris-HCl buffer by EPR spectroscopy.
Chromium(V) Produces
Cr-DNA Adducts and
Carbon-based Radicals
Produce Single-strand Breaks
Comparison of the Cr-DNA binding and
plasmid nicking experiments to the inter-
mediates detected in EPR spectra suggests
that Cr(V) produces Cr-DNA adducts and
that the carbon-based radicals are responsible
for DNA single-strand breaks. The higher
binding of Cr to calf thymus DNA in
HEPES vs Tris-HCl buffer is proportional
to the increased levels of Cr(V) in HEPES
observed by EPR. If Cr(V) were the more
reactive species in the plasmid nicking
study, the nicking should be higher in
HEPES buffer relative to Tris-HCl; but the
opposite was observed. The 1.6-fold higher
nicking in Tris-HCl vs HEPES is consistent
with the 2-fold higher level of DMPO-
adducts in Tris-HCl buffer detected by
EPR. This buffer effect can also be used to
argue against reactivity of ascorbate radical,
since ascorbate radical was observed at
higher concentration in HEPES vs Tris-HCl
Figure a Levels of chromium bound to double-stranded vs single-stranded calf thymu-s DNA produced upon reaction of
DNA with Cr(VI) in the presence of ascorbate in HEPES vs Tris-HCI buffers. Native (DS) or denatured (SS) calf thymus
DNA (1.8 mM DNA-P) was incubated with Cr(VI) (1.8 mM, from K2Cr207) and ascorbic acid (1.8 mM) in either 0.05 M Tris-
HCI buffer (pH 7.0, 37'C) or 0.10 M HEPES buffer (pH 7.0, 37C). All buffers and ascorbate solutions were treated with
cation exchange resin AG50W X 8 to remove trace iron. Ascorbate concentrations were measured as stated in Figure 1
caption. Incubations were carried out at 37° C for 30 min. NENsorb chromatography and dialysis was used to remove non-
covalently bound chromium from DNA (25). The amount of chromium bound to a sample of DNA was measured by
atomic absorption spectroscopy. DNA concentrations per sample were determined by the diaminobenzoic acid (DABA)
fluorometric assay (26). The amount of chromium measured in controls lacking DNA was subtracted from the amount of
chromium in reaction samples before calculation of binding ratios. Values are the averages of binding ratios ± SD. (n=16
for reactions in HEPES buffer, n=10 for reactions in Tris-HCI buffer, p= 0.01 for all data.)
buffer. It would be expected that ascorbate
radical would be less reactive with DNA
than the carbon-based radicals since ascorbate
radical is too stable to react with DMPO.
The Cr-DNA binding results presented
here are consistent with previous work that
showed a correlation between Cr-DNA
adducts and Cr(V) produced from the
reaction of Cr(VI) with dithiothreitol, ,B-
mercaptoethanol, cysteine, and glutathione
(13). While the role of free radicals in
DNA cleavage has been established above
and elsewhere (14), the reactivity of Cr(V)
with DNA in terms of producing single
strand breaks is less clear. Farrell et al. (15)
have reported that the Cr(V) complex of 2-
ethyl-2-hydroxybutanoate caused strand
breaks in pUC9 DNA at pH<5; however,
instability of the Cr(V) complex at higher
pH prevented the same study at physiologic
pH. Kortenkamp et al. (16) observed
strand breaks in bacteriophage PM2 DNA
after incubation with a Cr(V) species pre-
pared from the reduction of Cr(VI) by glu-
tathione; however, this nicking was shown
later to be dependent on contaminating
iron (17). A different reactivity toward
DNA for Cr(V) vs free radicals was
observed for the reduction of Cr(VI) by
gluthathione in the presence or absence of
H202 (18) where single-strand breaks were
only observed in the presence of H202
under conditions which were shown to
generate hydroxyl radical, -OH. In the
absence of H202, the Cr(V) that was gen-
erated upon reaction of Cr(VI) with glu-
tathione produced Cr-DNA adducts only.
Under our experimental conditions the free
radicals were more reactive than Cr(V) in
the production of single-strand breaks,
since the level of strand breakage correlated
with level of free radicals but not with
Cr(V), and since DMPO, a radical trap
that did not affect Cr(V), decreased the
level of strand breakage. However, the lack
of Cr(V)'s reactivity was not determined.
There is evidence to suggest that Cr(V)
and radical intermediates will produce similar
types of DNA damage in in vivo systems.
Chromium(V) has been shown to have a
significant lifetime in vivo (19,20).
Chromium(V) has been detected by EPR
in chick embryo red blood cells (19) and
liver (20) after in vivo treatment of chick
embryos with Cr(VI). The Cr(V) signal in
liver reached a maximum at 70 min after
treatment and was detectable for 240 min.
The Cr(V) signals observed in vivo had g
values of 1.981, 1.984-5, and 1.987
(19,20). The Cr(V) signal with g=1.980
observed in this study of Cr(VI) with
ascorbate in HEPES buffer is similar to the
Cr(V) signal with g= 1.981 observed in vivo
in chick embryo red blood cells. The Cr(V)
species formed in vivo (20) was detectable
in liver cells at a lower dose of Cr(VI) than
was necessary to detect Cr(V) in red blood
cells. This difference in the levels of Cr(V)
correlates with the DNA damage observed
in chick embryo liver and blood cells. In
chick embryo liver, Cr(VI) treatment
induced DNA cross-links but not strand
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Figure 4. Levels of nicking of pBR322 DNA upon reaction with Cr(VI) in the presence of ascorbate in HEPES versus Tris-
HCI buffers. Reaction mixtures (10 pl) contained 1.0 pg pBR322 DNA (0.36 pM DNA-P), 1.8 mM Cr(VI) (from K2Cr207), 1.8
mM sodium ascorbate and 15 pM DETAPAC in either 0.10 M HEPES or 0.05 M Tris-HCI buffers (pH 7.0, 37° C). Control
mixtures contained Cr(VI) with DNA or ascorbate with DNA. Reactions were incubated for 30 min at 37° C and were ter-
minated by cooling in an ice bath. Loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF, 30% glycerol in
water) was added to each reaction at 2 pI/l 0 pl reaction volume. Reactions were analyzed by agrose gel electrophoresis
on 0.7% agrose gels containing 0.5 pg/mI ethidium bromide, against 0.8 pg of 1.0 kB Lamda molecular weight marker
DNA. Samples were electrophoresed at 120 V (4 V/cm) for 8 to 12 hr. Gels were destained in water for at least 2 hr, and
photographs were taken with Polaroid 55 film under ultraviolet light. Gel band intensities representing supercoiled and
nicked plasmid DNA were determined with a Helena Laboratories Quick Scan R&D Densitometer and HP3396A
Integrator. Multiple comparisons of data groups were accomplished by a one-way analysis of variance (ANOVA) and
evaluated by a paired, two-tailed t-test. Data points having no letters (a-d) in common are significant at p<0.05.
breaks, whereas in chick embryo red blood
cells Cr(VI) induced DNA strand breaks
in the absence of cross-links (21). This is
consistent with the in vitro Cr(V) and rad-
ical reactivity presented in this work.
Sugiyama et al. (22) have reported that
pretreatment of Chinese hamster V-79
cells with ascorbate followed by incubation
with Cr(VI) reduced the amount of Cr(V)
formed as an intermediate relative to the
final Cr(III) product. They also found pre-
treatment with ascorbate increased the
amount of DNA-protein cross-links and
decreased the chromate-induced alkali-
labile sites. In contrast to the observations
presented here and elsewhere (18,21),
Sugiyama et al. concluded that Cr(V) was
responsible for the alkali-labile sites and
that Cr(III) caused the DNA-protein
cross-links. However, it has been shown
above that radicals and Cr(V) can be
formed concomitantly; but the presence of
radicals was not explored in the study of
Sugiyama et al. (22). More importantly,
no comparison can be made between these
studies (21,22) of the relative concentra-
tions of reducing agents in chick embryo
cells vs V-79 cells.
The experiments described here present
a model system that may be useful in
understanding the reduction of Cr(VI) by
ascorbate in vivo. Just as the level of reac-
tive intermediates and resulting DNA
damage differ in HEPES and Tris-HCl
buffers, tissue-specific cellular components
affect the formation of reactive intermedi-
ates and DNA damage. The significance of
these in vitro results is shown by the corre-
lation to the in vivo chick embryo experi-
ments (19-21), in which the DNA
damage in different tissues was observed to
be consistent with the presence or absence
of Cr(V) and radicals. A broader picture is
emerging that suggests a role for Cr(V) as
the ultimate genotoxic form of chromium,
but also suggests that different reducing
environments will affect the formation and
stability of reactive intermediates, thus
producing varying types of DNA damage
in different tissues or assay systems.
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